The Legal Intelligencer | Commentary
By Steve Schain | January 17, 2019
Derived from identical plants, vastly easier to cultivate, and profoundly more profitable, industrial hemp always lacked legalized marijuana's sizzle.
By Clay Flaherty | January 16, 2019
In service to financial efficiency and vigorous representation of the public interest, municipalities and political subdivisions in Pennsylvania increasingly rely upon the expertise and acumen of outside counsel to assist them in their legal endeavors.
The Legal Intelligencer | Commentary
By Zachary J. Koslap | January 10, 2019
This column surveys some of the ways states have chosen to regulate the environmental impacts of cannabis legalization in an effort to understand which issues have been prime targets for regulation, where some regulatory inconsistencies between the states exist, and what may be growing targets for regulation in the future.
The Legal Intelligencer | Commentary
By David J. Carney | December 13, 2018
Vaccines are an integral part of the American society and have been instrumental in eliminating dangerous diseases that once crippled millions of people, curtailing the spread of contagious diseases that are recurrent in the population, and keeping health care costs down
By Phillip Bantz | December 10, 2018
Oler will be primarily responsible for business development, investor relations and legal affairs. He'll be focused on forging relationships with global partners to help advance an Onconova cancer drug called Rigosertib.
By Max Mitchell | December 6, 2018
A federal jury in Pennsylvania has hit Israel-based drugmaker Teva Pharmaceuticals with a more than $6.1 million verdict over claims that a manager discriminated against an American employee.
The Legal Intelligencer | Commentary
By Carl W. Hittinger and Jeanne-Michele Mariani | November 30, 2018
Nearly four years ago, “Pharma bro” Martin Shkreli made headlines after his pharmaceutical company raised the price of the brand name drug Daraprim…
The Legal Intelligencer | News
By Max Mitchell | November 26, 2018
A jury from the U.S. District Court for the Eastern District of Pennsylvania on Monday awarded $1.16 million in compensatory damages and $5 million in punitive damages to a plaintiff who said his Israeli manager discriminated against him on the basis of age and American nationality.
The Legal Intelligencer | News
By Lizzy McLellan | November 5, 2018
Impax Laboratories argued that Goodwin Procter shouldn't represent Teva Pharmaceuticals, because the firm had previously represented both Teva and Impax in an underlying case.
The Legal Intelligencer | News
By P.J. D'Annunzio | October 30, 2018
Two pharmaceutical companies seeking to swap a Federal Trade Commission case over paying to delay the release of generic drugs with an administrative remedy were disappointed by a federal judge Tuesday.
Presented by BigVoodoo
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
We are seeking an associate to join our Employee Benefits practice. Candidates should have three to six years of employee benefits experienc...
Associate attorney position at NJ Immigration Law firm: Leschak & Associates, LLC, based in Freehold, NJ, is looking for a full time ass...
Seeking a compassionate and experienced estate administration attorney for growing boutique estate planning and elder law practice. Huge eq...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS